Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke: call 911. Nursing recognition & response.

Susan B Stark1

  • 1Shawnee Mission Regional Cardiac and Vascular Center, Shawnee Mission, KS, USA.

The Kansas Nurse
|December 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Legislative report.

The Kansas nurse·2009
Same journal

Guidelines for the registered nurse in accepting or rejecting a work assignment.

The Kansas nurse·2009
Same journal

2008 House of Delegates. Takes action on major health and nursing issues.

The Kansas nurse·2009
Same journal

If it is on the shelf it must be safe, right?

The Kansas nurse·2009
Same journal

Spread too thin: faculty perpectives about faculty-student ratios in Kansas.

The Kansas nurse·2009
Same journal

Kansas Health Institute issue brief: employer-sponsored insurance in Kansas.

The Kansas nurse·2008
See all related articles

Despite the proven benefits of tissue plasminogen activator (tPA) in reducing stroke disability, less than 5% of eligible stroke patients receive this critical treatment. This highlights a significant gap between established stroke treatment guidelines and actual clinical practice.

Area of Science:

  • Neurology
  • Public Health
  • Emergency Medicine

Background:

  • Stroke is a leading cause of death and disability in the U.S.
  • Tissue plasminogen activator (tPA) is a proven treatment for minimizing stroke-related disability.
  • National guidelines and public awareness campaigns for tPA have been established.

Purpose of the Study:

  • To assess the utilization of tPA in stroke treatment.
  • To identify barriers to tPA administration in clinical practice.

Main Methods:

  • Analysis of stroke treatment data.
  • Review of clinical guidelines and treatment pathways.
  • Evaluation of public education campaign effectiveness.

Main Results:

Related Experiment Videos

  • Less than 5% of stroke victims were treated with tPA five years after national symposium.
  • Established guidelines and pathways did not translate to widespread tPA use.

Conclusions:

  • There is a significant gap between recommended stroke care and actual patient treatment.
  • Barriers to tPA administration require further investigation and intervention.
  • Improving tPA utilization is crucial for reducing stroke-related disability.